Neurodex at the Bio-Neuroscience Conference
Showcasing Pioneering Diagnostic Technologies
We proudly announce that Neurodex will play a significant role at the forthcoming Bio-Neuroscience Conference, highlighting our innovative diagnostic technologies for neurodegenerative diseases. Oded Biran, our distinguished SEO, will present our leading-edge work in developing blood-based biomarkers and leveraging cell-specific extracellular vesicles (exosomes) for precise diagnostics.
About Our Innovations
Neurodex is dedicated to advancing precision medicine in neurodegeneration. Our suite of diagnostic tools aims to revolutionize the early detection and treatment of conditions such as Lewy body dementia, Alzheimer’s disease, Parkinson’s disease, and ALS. Our technology’s potential to identify synucleinopathies through blood-based markers represents a significant leap forward in neurodegenerative disease diagnostics.
Join Us
The Bio-Neuroscience Conference is a premier event for exploring cutting-edge developments in neuroscience. For more details, please visit https://www.broadreach-global.com/bio-neuroscience.
Schedule a Meeting
We invite interested parties to meet with Oded Biran to discuss our technologies and explore potential collaborations. Please contact us at info@neurodex.co to arrange a meeting.
Stay Informed
Keep an eye on this page for the latest updates on Neurodex’s participation in the Bio-Neuroscience Conference and advancements in our diagnostic technologies.
Exosomes
Exosomes are small vesicles that cells release, crucial for cell-to-cell communication. They carry RNA, DNA, and proteins, mirroring their originating cell’s state. Importantly, exosomes can cross the blood-brain barrier and appear in blood samples. This feature is groundbreaking for diagnosing neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS non-invasively, promising earlier detection and intervention.
Neurodegenerative diseases
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, ALS, and Lewy Body Dementia, progressively damage the nervous system. They often involve abnormal protein accumulations leading to cell death. Fortunately, studying exosomes opens new paths for understanding these conditions, enabling the early identification of biomarkers. This advancement could significantly impact treatment strategies, potentially slowing or halting disease progression.
